Aperiomics Names Wynemah Fuller Operations Director

By | 2018-01-19T22:38:27+00:00 December 7th, 2017|

 

OriginalArticle: http://dc.citybizlist.com/article/455893/aperiomics-names-wynemah-fuller-operations-director

Ashburn, VA , December 7, 2017 — Aperiomics, a biotechnology company that harnesses the power of deep next-generation sequencing to identify all known pathogens (bacteria, virus, fungi or parasite) in a single test, today announced that Wynemah Fuller has joined the company as director of operations.

Fuller brings to Aperiomics decades of experience in sales and administration. She will ensure that the company continues to improve its internal processes and customer service, including working with medical insurance companies and sending out test kits in a timely manner. Fuller is from the Dallas-Ft. Worth area. She worked in sales in the oil industry in Midland, TX from the time she was 20 years old. She also started an online floral business with customers across the country.

“Doctors and their patients count on us to be responsive and get everything right the first time,” said company CEO and co-founder Dr. Crystal Icenhour. “Wynemah is a great addition to our team and will help us improve all of our processes and effectiveness for the benefit of our team and our customers.  We’re excited to welcome her aboard.”

 

About Aperiomics

Aperiomics is the only company identifying every bacteria, DNA virus, fungi and parasite in one test.  Clinicians and patients call on Aperiomics to identify infectious diseases that other tests cannot identify. The only company of its kind and scope in the world, Aperiomics identifies every known pathogen (bacteria, virus, fungi or parasite) in a single test through next-generation sequencing of the DNA or RNA in any sample (patient, environmental, etc.).  The complete genetic fingerprint of that sample is then compared to the Aperiomics Microbial Database™- the most comprehensive database of microorganisms, including the world’s largest collection of pathogens.  This breakthrough is only possible through Aperiomics and can be used to identify unknown/chronic infections, limit the use of antibiotics and solve difficult medical cases. Patients and their families often contact Aperiomics directly after hearing about our successes in helping others.  Aperiomics was named Life Sciences Innovators of the Year in 2016 and a finalist in the 2017 Greater Washington Innovation Awards.  For more information, visit www.aperiomics.com or call (703) 229-0406.